These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Physicochemical and Functional Characterization of Differential CRISPR-Cas9 Ribonucleoprotein Complexes. Camperi J; Moshref M; Dai L; Lee HY Anal Chem; 2022 Jan; 94(2):1432-1440. PubMed ID: 34958212 [TBL] [Abstract][Full Text] [Related]
3. Poly-sgRNA/siRNA ribonucleoprotein nanoparticles for targeted gene disruption. Ha JS; Lee JS; Jeong J; Kim H; Byun J; Kim SA; Lee HJ; Chung HS; Lee JB; Ahn DR J Control Release; 2017 Mar; 250():27-35. PubMed ID: 28167287 [TBL] [Abstract][Full Text] [Related]
4. Aspartic acid functionalized PEGylated MSN@GO hybrid as an effective and sustainable nano-system for in-vitro drug delivery. Rahmatolahzadeh R; Hamadanian M; Ma'mani L; Shafiee A Adv Med Sci; 2018 Sep; 63(2):257-264. PubMed ID: 29486375 [TBL] [Abstract][Full Text] [Related]
5. Cholesterol-rich lipid-mediated nanoparticles boost of transfection efficiency, utilized for gene editing by CRISPR-Cas9. Hosseini ES; Nikkhah M; Hosseinkhani S Int J Nanomedicine; 2019; 14():4353-4366. PubMed ID: 31354265 [No Abstract] [Full Text] [Related]
6. Graphene oxide-mediated Cas9/sgRNA delivery for efficient genome editing. Yue H; Zhou X; Cheng M; Xing D Nanoscale; 2018 Jan; 10(3):1063-1071. PubMed ID: 29266160 [TBL] [Abstract][Full Text] [Related]
7. Strategies in the delivery of Cas9 ribonucleoprotein for CRISPR/Cas9 genome editing. Zhang S; Shen J; Li D; Cheng Y Theranostics; 2021; 11(2):614-648. PubMed ID: 33391496 [TBL] [Abstract][Full Text] [Related]
8. Highly Efficient Mouse Genome Editing by CRISPR Ribonucleoprotein Electroporation of Zygotes. Chen S; Lee B; Lee AY; Modzelewski AJ; He L J Biol Chem; 2016 Jul; 291(28):14457-67. PubMed ID: 27151215 [TBL] [Abstract][Full Text] [Related]
9. Direct Cytosolic Delivery of CRISPR/Cas9-Ribonucleoprotein for Efficient Gene Editing. Mout R; Ray M; Yesilbag Tonga G; Lee YW; Tay T; Sasaki K; Rotello VM ACS Nano; 2017 Mar; 11(3):2452-2458. PubMed ID: 28129503 [TBL] [Abstract][Full Text] [Related]
10. Targeted Genome Editing Using DNA-Free RNA-Guided Cas9 Ribonucleoprotein for CHO Cell Engineering. Shin J; Lee N; Cho S; Cho BK Methods Mol Biol; 2018; 1772():151-169. PubMed ID: 29754227 [TBL] [Abstract][Full Text] [Related]
11. Versatile modification of the CRISPR/Cas9 ribonucleoprotein system to facilitate in vivo application. Sun B; Chen H; Gao X J Control Release; 2021 Sep; 337():698-717. PubMed ID: 34364918 [TBL] [Abstract][Full Text] [Related]
12. A Guanidinobenzol-Rich Polymer Overcoming Cascade Delivery Barriers for CRISPR-Cas9 Genome Editing. Liang S; Ma N; Li X; Yun K; Meng QF; Ma K; Yue L; Rao L; Chen X; Wang Z Nano Lett; 2024 Jun; 24(23):6872-6880. PubMed ID: 38683656 [TBL] [Abstract][Full Text] [Related]
13. An engineered exosome for delivering sgRNA:Cas9 ribonucleoprotein complex and genome editing in recipient cells. Ye Y; Zhang X; Xie F; Xu B; Xie P; Yang T; Shi Q; Zhang CY; Zhang Y; Chen J; Jiang X; Li J Biomater Sci; 2020 May; 8(10):2966-2976. PubMed ID: 32342086 [TBL] [Abstract][Full Text] [Related]
14. A quaternary ammonium-based nanosystem enables delivery of CRISPR/Cas9 for cancer therapy. Zhang M; Sun S; Liang X; Liu Z; Yin J; Li Q; Yang S Biomater Sci; 2024 Feb; 12(5):1197-1210. PubMed ID: 38240497 [TBL] [Abstract][Full Text] [Related]
15. Rationally designed nanoparticle delivery of Cas9 ribonucleoprotein for effective gene editing. Chae SY; Jeong E; Kang S; Yim Y; Kim JS; Min DH J Control Release; 2022 May; 345():108-119. PubMed ID: 35247491 [TBL] [Abstract][Full Text] [Related]
16. Curcumin-loaded guanidine functionalized PEGylated I3ad mesoporous silica nanoparticles KIT-6: practical strategy for the breast cancer therapy. Ma'mani L; Nikzad S; Kheiri-Manjili H; Al-Musawi S; Saeedi M; Askarlou S; Foroumadi A; Shafiee A Eur J Med Chem; 2014 Aug; 83():646-54. PubMed ID: 25014638 [TBL] [Abstract][Full Text] [Related]
17. Lipofection-mediated genome editing using DNA-free delivery of the Cas9/gRNA ribonucleoprotein into plant cells. Liu W; Rudis MR; Cheplick MH; Millwood RJ; Yang JP; Ondzighi-Assoume CA; Montgomery GA; Burris KP; Mazarei M; Chesnut JD; Stewart CN Plant Cell Rep; 2020 Feb; 39(2):245-257. PubMed ID: 31728703 [TBL] [Abstract][Full Text] [Related]
18. Delivery of Cas9/sgRNA Ribonucleoprotein Complexes via Hydroxystearyl Oligoamino Amides. Kuhn J; Lin Y; Krhac Levacic A; Al Danaf N; Peng L; Höhn M; Lamb DC; Wagner E; Lächelt U Bioconjug Chem; 2020 Mar; 31(3):729-742. PubMed ID: 31967454 [TBL] [Abstract][Full Text] [Related]
19. Methods for CRISPR-Cas as Ribonucleoprotein Complex Delivery In Vivo. Bykonya AG; Lavrov AV; Smirnikhina SA Mol Biotechnol; 2023 Feb; 65(2):181-195. PubMed ID: 35322386 [TBL] [Abstract][Full Text] [Related]
20. Delivering Cas9/sgRNA ribonucleoprotein (RNP) by lentiviral capsid-based bionanoparticles for efficient 'hit-and-run' genome editing. Lyu P; Javidi-Parsijani P; Atala A; Lu B Nucleic Acids Res; 2019 Sep; 47(17):e99. PubMed ID: 31299082 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]